Unknown

Dataset Information

0

Transcription profiling by array of human lung cancer cells after treatment with dasatinib, imatinib, nilotinib or PD0325901


ABSTRACT: Cell Line: This experiment was designed to measure the transcriptional responses to four kinase inhibitors across a five-logarithm dose range. The A549 human lung cancer cell line was treated with dasatinib, imatinib or nilotinib (4 hours and 20 hours) or PD0325901 (4 hours). Treatments used a 12-point dose range (30 uM with 3-fold dilutions down to 0.17 nM; 0.5% DMSO vehicle for all treatments). Experimental design prevented row or column handling effects being confounded with dose effect.

ORGANISM(S): Homo sapiens

SUBMITTER: Ji RR 

PROVIDER: S-ECPF-TABM-585 | biostudies-other | 2009 Sep

REPOSITORIES: biostudies-other

Similar Datasets

2008-12-31 | E-TABM-585 | biostudies-arrayexpress
| S-EPMC3000369 | biostudies-literature
| S-ECPF-GEOD-19188 | biostudies-other
| S-EPMC10133852 | biostudies-literature
| S-ECPF-GEOD-13309 | biostudies-other
| S-ECPF-MEXP-2546 | biostudies-other
| S-ECPF-GEOD-18842 | biostudies-other
| S-ECPF-TABM-450 | biostudies-other
| S-ECPF-MEXP-231 | biostudies-other
| S-ECPF-MEXP-440 | biostudies-other